Post-Authorization Safety of Lenalidomide Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: Early Safety Report of Turkish Pass Study

Abstract

Description

Keywords

Citation

Endorsement

Review

Supplemented By

Referenced By